Skip to main content

About the Editor

Professor Shichuo Li 

Professor Li is the Founding President of the China Association Against Epilepsy (CAAE). He is also Advisor for Public Health of ILAE Executive Committee and the Co-chairmen of the ILAE/IBE Global Outreach Taskforce.

Professor Li was formerly the Assistant Director-General of the World Health Organization (WHO), WHO Representative of South Pacific (1998 - 2003), the Director-General of the Department of International Cooperation at the Ministry of Health, China (1992 - 1997)and the Vice Director of the Beijing Municipal Health Bureau (1987 - 1992).

In the 1980s, Prof. Li worked at the National Institutes of Health (NIH) at Bethesda, Maryland, USA as a visiting scientist for 2 years. Over the past years, besides all the administrative and International cooperation activities, Prof. Li has also dedicated himself to the epidemiology research of neurological diseases as well as the prevention and control of cerebrovascular diseases and epilepsy in the community.  His research has gained more than 10 Beijing municipal and National science development awards.

Professor Li has published extensively with more than 70 articles in China as well as internationally.  As a chief editor, he has also published a book entitled ‘Epidemiology of Nervous System Diseases” and a “Green Book of Prevention and Control of Epilepsy in China”.

Latest Thematic Series

Virus and epilepsy

Call for paper: Ketogenic diet and epilepsy therapy

Acta Epileptologica invite you to submit the manuscript (like research, review, case report, perspective, letter, etc)  with the topic: Ketogenic diet and epilepsy therapy to share with the knowledge and points about the one of the important and common therapy of epilepsy. The editorial office is dedicated to process the submissions with highly priority.

The recommending themes: 
1. Investigation on the application of ketogenic diet at national level: state policy, application status etc.
2. Multicenter randomized controlled clinical trial of ketogenic therapy for refractory epilepsy patients.
3. Neuroprotective effect of ketogenic diet and its possible mechanism.
4. ketogenic diet in the clinical treatment of super refractory status epilepticus.
5. Patient management of ketogenic diet patient.

Deadline for submission:  August 31, 2021 

Welcome to submit!

Aims and scope

Acta Epileptologica is dedicated to advancing people’s understanding of epilepsy by providing a forum to share the latest research. The main focus of the journal covers all aspects related to epilepsy, topics include but are not limited to basic research, practical management of epilepsy, neuroimaging, therapeutic trials, case report, social and psychological burden. In addition to the mechanisms of epileptogenesis, broader comorbidities of epilepsy, new treatments and their measures.

Journal Announcement

Acta Epileptologica is now officially indexed in Directory of Open Access Journals (DOAJ)!

Welcome to visit!

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Official journal of

Annual Journal Metrics

  • Speed
    53 days to first decision for reviewed manuscripts only
    53 days to first decision for all manuscripts
    134 days from submission to acceptance
    36 days from acceptance to publication